Legal Opinion

In Re Oxycontin Antitrust Litigation

United States Judicial Panel on Multidistrict Litigation

Decided April 22, 2004No. MDL 1603PublishedCited by 3 opinions

1Opinion of the Court

314 F.Supp.2d 1388 (2004)

In re OXYCONTIN ANTITRUST LITIGATION

Connecticut Citizen Action Group, et al.

v.

Purdue Pharma Co., et al., C.A. No. 3:04-15

Mark Klein

v.

Purdue Pharma Co., et al., D. Connecticut, C.A. No. 3:04-39

Pamela Krause

v.

P.F. Laboratories, Inc., et al., S.D. New York, C.A. No.1:04-314

No. MDL 1603.

Judicial Panel on Multidistrict Litigation.

April 22, 2004.

Before WM. TERRELL HODGES, Chairman, JOHN F. KEENAN, BRUCE M. SELYA, D. LOWELL JENSEN, J. FREDERICK MOTZ, ROBERT L. MILLER, JR., and KATHRYN H. VRATIL, Judges of the Panel.

TRANSFER ORDER

WM. TERRELL HODGES, Chairman.

This litigation…

2Cases cited1 opinion

  1. Connecticut Citizen Action Group v. Purdue Pharma Co.United States Judicial Panel on Multidistrict Litigation · 2004

3Cited by3 opinions

  1. In re Gerber Probiotic Products Marketing & Sales Practices LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012
  2. In Re: Oxycontin Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 2008
  3. Kentucky v. Purdue Pharma, L.P.United States Judicial Panel on Multidistrict Litigation · 2008

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API